Both low HDL-C and elevated Lp(a) are well-documented to be closely related to the progression of atherosclerosis and ISR, further supporting Lp(a) as a target for interventions aimed at endothelial injury and atherosclerosis (40–42). The gene discussed is LPA; the disease is atherosclerosis.